Sort by

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 37


Cost effectiveness of defibrillation by targeted responders in public settings.

Nichol G, Valenzuela T, Roe D, Clark L, Huszti E, Wells GA.

Circulation. 2003 Aug 12;108(6):697-703. Epub 2003 Aug 4. Erratum in: Circulation. 2004 Jun 29;109(25):3256.


Demographics and concomitant disorders in heart failure.

Krum H, Gilbert RE.

Lancet. 2003 Jul 12;362(9378):147-58. Review.


Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators.

JAMA. 2003 May 28;289(20):2685-94.


Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators.

N Engl J Med. 2003 Apr 3;348(14):1309-21. Epub 2003 Mar 31. Erratum in: N Engl J Med. 2003 May 29;348(22):2271.


Mode of death in heart failure: findings from the ATLAS trial.

Poole-Wilson PA, Uretsky BF, Thygesen K, Cleland JG, Massie BM, Rydén L; Atlas Study Group. Assessment of treatment with lisinopril and survival.

Heart. 2003 Jan;89(1):42-8.


ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).

Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RI, Antman EM, Alpert JS, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC Jr; American College of Cardiology/American Heart Association Task Force on Practice Guidelines American College of Cardiology/American Heart Association/North American Society for Pacing and Electrophysiology Committee.

J Cardiovasc Electrophysiol. 2002 Nov;13(11):1183-99. No abstract available.


Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation.

Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P, Djiane P, Mabo P, Levy T, Gadler F, Bailleul C, Daubert JC.

Eur Heart J. 2002 Nov;23(22):1780-7.


Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes.

Curtin F, Altman DG, Elbourne D.

Stat Med. 2002 Aug 15;21(15):2131-44.


Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study.

Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV.

Arch Intern Med. 2002 Aug 12-26;162(15):1689-94.


Cardiac resynchronization therapy for heart failure: biventricular pacing and beyond.

Abraham WT.

Curr Opin Cardiol. 2002 Jul;17(4):346-52. Review.


Quantifying heterogeneity in a meta-analysis.

Higgins JP, Thompson SG.

Stat Med. 2002 Jun 15;21(11):1539-58.


Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay.

Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Huth C, Schöndube F, Wolfhard U, Böcker D, Krahnefeld O, Kirkels H; Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group.

J Am Coll Cardiol. 2002 Jun 19;39(12):2026-33.


Cardiac resynchronization in chronic heart failure.

Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J; MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation.

N Engl J Med. 2002 Jun 13;346(24):1845-53.


Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: prospective haemodynamic study.

Garrigue S, Bordachar P, Reuter S, Jaïs P, Kobeissi A, Gaggini G, Haïssaguerre M, Clementy J.

Heart. 2002 Jun;87(6):529-34.


Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure.

Baldasseroni S, Opasich C, Gorini M, Lucci D, Marchionni N, Marini M, Campana C, Perini G, Deorsola A, Masotti G, Tavazzi L, Maggioni AP; Italian Network on Congestive Heart Failure Investigators.

Am Heart J. 2002 Mar;143(3):398-405.


Multiattribute and single-attribute utility functions for the health utilities index mark 3 system.

Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M.

Med Care. 2002 Feb;40(2):113-28.


A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators.

N Engl J Med. 2001 Dec 6;345(23):1667-75.


Beta-blockers in congestive heart failure. A Bayesian meta-analysis.

Brophy JM, Joseph L, Rouleau JL.

Ann Intern Med. 2001 Apr 3;134(7):550-60.


Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC; Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators.

N Engl J Med. 2001 Mar 22;344(12):873-80.


Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995.

MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ.

Circulation. 2000 Sep 5;102(10):1126-31.

Items per page

Supplemental Content

Write to the Help Desk